Pseudomyxoma Peritonei: Clinical Trials

2 trials for Pseudomyxoma Peritonei, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 2

Follow Pseudomyxoma Peritonei: new trials by email Literature Review of Pseudomyxoma Peritonei trials Research Report on Pseudomyxoma Peritonei

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)7982017-01-302026-06-17
Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
PrevPac (Prevacid, Amoxicillin, Clarithromycin) - Pseudomyxoma Peritonei, Appendiceal Neoplasms
Phase 2Active not recruitingMercy Medical Center802015-01-012024-11-19

Narrower conditions

Adenocarcinoma, Bronchiolo-Alveolar (1)  ·  Adenocarcinoma, Mucinous (1)  ·  Adrenocortical Carcinoma (1)  ·  Appendiceal Neoplasms (1)  ·  Bile Duct Neoplasms (1)  ·  Carcinoma, Acinar Cell (1)  ·  Carcinoma, Adenoid Cystic (1)  ·  Carcinoma, Basal Cell (1)  ·  Carcinoma, Endometrioid (1)  ·  Carcinoma, Giant Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Carcinosarcoma (1)  ·  Cholangiocarcinoma (1)  ·  Chordoma (1)

Broader conditions

Adenocarcinoma (2)  ·  Carcinoma (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Cystic, Mucinous, and Serous (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Adenocarcinoma of Lung (1)  ·  Adenocarcinoma, Mucinous (1)  ·  Adnexal Diseases (1)  ·  Adrenal Cortex Diseases (1)

Interventions

Amoxicillin (1)  ·  CTLA-4 Antigen (1)  ·  Clarithromycin (1)  ·  Ipilimumab (1)  ·  Lansoprazole (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Nivolumab (1)  ·  Specimen Handling (1)

Sponsors

Mercy Medical Center (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  Guam (1)

Top investigators

Armando Sardi, M.D. (1)  ·  Sandip P Patel (1)  ·  Scott Merrell, PhD (1)

Results publications

PMID 31969335, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34716198, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790

NIH funding

U10CA180888 (1)